Delivery Order SPE2DB22D2005-SPE2DB25FJRL6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This competitively awarded, firm fixed-price contract requires performance at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.06 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract employs firm fixed price terms and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $1,043.96. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $4,497.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100 count) with an ultimate completion date of August 4, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Quillichew ER 40 mg chew tablets (100-count units) with a ceiling value of $1,341.21. This is a firm fixed price delivery order executed under a non-competitive set-aside structure, with performance to be completed by August 8, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,088.72 to AmerisourceBergen Drug Corp for Quillichew ER Chew Tabs 40mg, a medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,009 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the contract. The Defense Logistics Agency is the funding agency for this delivery order placed against an...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRL6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,879.40 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. As the nation's leading pharmaceutical distributor, AmerisourceBergen maintains a significant portfolio of federal medical contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, delivering medications across multiple therapeutic domains including neurological, endocrinological, pain management, and specialty pharmaceutical categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/13/25 |